Furthermore, the abundance of fibronectin and vimentin—mesenchymal markers—were significantly upregulated in EBV-positive NPC cells, not EBV-negative NPC cells (eFigure 3 in Supplement 1). The gene discussed is FN1; the disease is nasopharyngeal carcinoma.